Quinlan Paul T — SEC Form 4 filings
SEC reporting owner CIK 1333277. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-16 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 5 filings — 59,505 shares, $5,940,105 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 14,696 shares @ $107.97 ($1,586,779) in Oruka Therapeutics, Inc., filed 2026-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | General Counsel | 6 | — | 9 legs · 54,505 sh · $5,822,207 | 7 |
| CymaBay Therapeutics, Inc. (CBAY) | General Counsel | 4 | — | 1 leg · 5,000 sh · $117,898 | 13 |
Form 4 filings — Quinlan Paul T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,039 @ $95.71 | EDGAR |
| 2026-08-14 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 10,000 @ $7.80 · Option exercise (M): 42,000 @ $12.50 · Sale (S): 3,630 @ $106.05 · Sale (S): 10,434 @ $107.14 · Sale (S): 14,696 @ $107.97 · Sale (S): 10,200 @ $109.11 · +4 more | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 733 @ $69.69 | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 733 @ $41.30 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 162,500 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 41,824 · Disposition to issuer (D): 28,438 · Disposition to issuer (D): 233,176 (derivative) · Disposition to issuer (D): 22,167 (derivative) · Disposition to issuer (D): 107,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) · +1 more | EDGAR |
| 2024-03-15 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 41,824 @ $7.89 · Option exercise (M): 41,824 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 28,438 @ $0 · Grant/award (A): 105,625 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $23.58 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1333277 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →